A Pilot Study of Yoga for Symptoms of Nerve Damage Caused by Chemotherapy

Full Title

Yoga for Chemotherapy - Induced Peripheral Neuropathy in Breast and GYN Cancer Survivors: A Pilot Study

Purpose

Some types of chemotherapy used to treat breast cancer can cause damage to nerves (neuropathy), with symptoms such as tingling, numbness, muscle weakness, and pain in the hands and feet that can last and can affect functioning. Typically these symptoms are managed with medications. In this study, researchers want to see if yoga is effective for managing symptoms of nerve damage associated with chemotherapy for breast cancer.

Participants will be randomly placed in one of two groups. One group will have group yoga classes twice a week with home practice on the other days for eight weeks, followed by home practice only for four weeks. The second group will receive their standard medical care for 12 weeks, and will then be able to participate in eight weeks of group and home-based yoga, Researchers will compare symptom relief between the two groups.

Eligibility

To be eligible for this study, patients must meet several criteria, including but not limited to the following:

  • Patients must have moderate to severe neuropathy in the hands and/or feet 3 or more months after completing nerve-damaging chemotherapy for stage I-III breast cancer.
  • Patients who are already practicing yoga or receiving physical therapy may not participate.
  • Patients must be able to walk and do routine activities for more than half of their normal waking hours.
  • This study is for English-speaking patients age 18 and older.

For more information about this study and to inquire about eligibility, please contact the Integrative Medicine research team at 646-888-0844.

Protocol

17-449

Phase

Pilot

Investigator

Co-Investigators